Abstract
Melamine is an important and widely used organic industrial chemical. Recently, clinical findings of renal failure and kidney stones in infants have been associated with ingestion of melamine-contaminated infant formula. To understand the toxicity and clinical outcome of melamine exposure, repeated oral dose studies in rats and monkeys were performed to characterize the subchronic toxicity of melamine. Assessment of toxicity was based on mortality, clinical signs, body weights, ophthalmic findings, clinical pathology, gross pathology, organ weights, and microscopic observations. The first rat study was intended to be a 14-day oral study followed by an 8-day recovery period. The dose levels were 140, 700, and 1,400 mg/kg/day (lowered to 1,000 mg/kg/day subsequently due to mortality). Oral administration of melamine at 700 mg/kg/day for 14 consecutive days in rats produced compound-related clinical signs (red urine), decreased body weights, and changes in clinical pathology (increased serum urea nitrogen and creatinine) and anatomical pathology (renal tubular cell debris, crystal deposition, and hyperactive regeneration of renal tubular epithelium). The kidney was identified as the target organ. Oral administration at 1,400 mg/kg/day (subsequently lowered to 1,000 mg/kg/day) resulted in animal death and moribundity. There were no treatment-related findings in the 140 mg/kg/day group. There were no compound-related findings in the high-dose recovery animals. The second rat study was a 5-day oral toxicity study with genomic biomarkers assayed in the kidney tissues. At the top dose of 1,050 mg/kg/day, similar clinical and anatomical pathology findings as described above were observed. The genes measured, Kim-1, Clu, Spp1, A2m, Lcn2, Tcfrsf12a, Gpnmb, and CD44, were significantly up-regulated (fivefold to 550-fold), while Tff3 was significantly down-regulated (fivefold). These results indicated that genomic markers could sensitively diagnose melamine-induced kidney injury. A 3-month oral study with 4-week recovery in monkeys was also conducted. In this monkey study, the animals were treated with melamine at doses of 60, 200, or 700 mg/kg/day. The administration of 700 mg/kg/day melamine by nasal-gastric gavage to monkeys resulted in test article-related clinical signs including turbid and whitish urine, urine crystals, red blood cell changes, increased serum alanine aminotransferase and kidney and/or liver weights, and microscopic findings including nephrotoxicity, pericarditis, and increased hematopoiesis. Nephrotoxicity was also noted at 200 mg/kg/day. It was concluded that the kidney is the primary target organ and the NOAEL was estimated to be 140 mg/kg/day in rats following a 14-day oral administration and 60 mg/kg/day in the monkey study.
Similar content being viewed by others
References
Bhalla V, Grimm PC, Chertow GM, Pao AC (2009) Melamine nephrotoxicity: an emerging epidemic in an era of globalization. Kidney Int 75:774–779
Brown CA, Jeong KS, Poppenga RH, Puschner B, Miller DM, Ellis AE, Kang K, Sum S, Cistola AM, Brown SA (2007) Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007. J Vet Diag Invet 19:525–531
Camacho L, Kelly KP, Beland FA (2011) Gamboa Costa G. Gene expression of biomarker of nephrotoxicity of F344 rats co-exposed to melamine and cyanuric acid for seven days. Toxicol Lett 206(2):166–171
Choi L, Kwak MY, Kwak EH, Kim DH, Han EY, Ron T, Bae JY, Ahn IY, Jung JY, Kwon MJ, Jang DE, Lim SK, Kwack SJ, Han SY, Kang TS, Kim SH, Kim HS, Lee BM (2010) Comparative nephrotoxicity induced by melamine, cyanuric acid, or a mixture of both chemicals in either Sprague-Dawley rats or renal cell lines. J Toxicol Environ Health A 73(21–22):1407–1419
Dobson RL, Motlagh S, Quijano M, Cambron RT, Baker TR, Pullen AM, Regg BT, Bigalow-Kern AS, Vennard T, Fix A, Reimschuessel R, Overmann G, Shan Y, Daston GP (2008) Identification and characterization of toxicity of contaminants in pet food leading to an outbreak of renal toxicity in cats and dogs. Toxicol Sci 106(1):251–262
Hammond BG, Barbee SJ, Inoue T, Ishida N, Levinskas GJ, Stevens MW, Wheeler AG, Cascieri T (1986) A review of toxicology studies on cyanurate and its chlorinated derivatives. Environ Health Perspet 69:287–292
Jacob CC, Reimschuessel R, Von Tungeln LS, Olson GR, Warbritton AR, Hattan DG, Beland FA (2011) Gamboa da Costa G. Dose-response assessment of nephrotoxicity from a 7-day combined exposure to melamine and cyanuric acid in F344 rats. Toxicol Sci 119(2):391–397
Jacob CC, Von Tungeln LS, Vanlandingham M, Beland FA (2012) Gamboa da Costa G. Pharmacokinetics of melamine and cyanuric acid and their combination in F344 rats. Toxicol Sci 126(2):317–324
Jiang Y, Gerhold DL, Holder DJ, Figueroa DJ, Bailey WJ, Guan P et al (2007) Diagnosis of drug-induced renal tubular toxicity using global gene expression profiles. J Transl Med 5:47
Lipschitz WL, Stocky E (1945) The mode of action of three new diuretics—–melamine, adenine and formoguanamine. J Pharmacol Exp Ther 83:235–249
Mcpharon T (2007) Melamine and cyanuric interaction may play part in the illness from recalled pet food, AVMA Press Release
National Research Council (NRC) (2011) Guide for the care and use of laboratory animals, 8th edn, National Academies Press, Washington
Pang J, Li GQ, Li CR, Yang XY, Lu X, Hu XX, Zhai QQ, Zhang WX, Jiang JD, You XF (2011) Toxicokinetic study of melamine in the presence and absence of cyanuric acid in rats. J Appl Toxicol. doi:10.1002/jat.1764
Park D, Kim TK, Choi YJ, Lee SH, Bae DK, Yang G, Yang YH, Joo SS, Choi EK, Ahn B, Kim JC, Kim KS, Kim YB (2011) Increased nephrotoxicity after combined administration of melamine and cyanuric acid in rats. Lab Anim Res 27(1):25–28
Puschner B, Poppenga RH, Lowenstine LJ, Filigenzi MS, Pesavento PA (2007) Assessment of melamine and cyanuric acid toxicity in cats. J Vet Diagn Invest 19:616–624
Qualified biomarker (2012) http://c-path.org/PSTCRegulatory.cfm
Stine CB, Reimschuessel R, Gieseker CM, Evans ER, Mayer TD, Hasbrouck NR, Tall E, Boehmer J, da Costa GG, Ward JL (2011) A no observable adverse effects level (NOAEL) for pigs fed melamine and cyanuric acid. Regul Toxicol Pharmacol 60(3):363–372
Sun N, ShenY He LJ (2010) Histopathological features of the kidney after acute renal failure from melamine. N Engl J Med 362(7):662–664
Zhang Q, Gamboa da Costa G, Vontungelin L, Jacob C, Brown R, Goering P (2012) Urinary biomarker detection of melamine and cyanuric acid induced kidney injury in rats. Toxicol Sci [Epub ahead of print]
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Early, R.J., Yu, H., Mu, X.P. et al. Repeat oral dose toxicity studies of melamine in rats and monkeys. Arch Toxicol 87, 517–527 (2013). https://doi.org/10.1007/s00204-012-0939-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-012-0939-7